Variante de COVID omicron: qué tan preocupado debería estar?

Las respuestas aún se desconocen, lo que hace que todos se preocupen aún más, mas miedo, y cuando tenemos miedo, como escribí en mi último libro, “COVID-19; la política del miedo y el poder de la ciencia,” we jump to the worst-case scenario, we over-personalize the risk, we lose the ability to reason.

Politicians and the media don’t help us. Our leaders want to be perceived as acting ahead of the risk, which is why the travel advisories are being put in place even though this variant has already spread into Europe and likely on into the United States, so travel restrictions now will do little.

BIDEN’S BORDER CRISIS – PREVENTABLE, PREDICTABLE AND DEADLY

The WHO, which has an office in South Africa, estaba, as usual, late in sounding the alarm, finally calling omicron a variant of concern on Friday, when the viral horses were already out of the barn.

How concerned should we be? The answer is to be found by addressing three basic scientific concerns.

Primero, how severe is the disease that this variant causes? The answer is somewhat reassuring so far. The numbers are small, but there is as of yet no evidence that it causes more severe disease than the original virus or the delta variant. De hecho, históricamente, as pandemic viruses evolve, they tend to become less deadly, as mutations that allow them to transmit more easily but not kill or severely sicken the host are favored.

De hecho, the second basic scientific concern with omicron is whether it spreads more easily than previous iterations of the virus, including delta. Time will tell whether the multitude of mutations it carries gives omicron this survival advantage. But so far, the case numbers are small, and it is too early to conclude anything on this one way or the other. Delta has predominated for months, precisely because it is far more transmissible than any of the other variants out there. Is omicron more transmissible than delta? We don’t know and we should not assume it is.

Federal support to Pfizer and Moderna could speed the development of new boosters to target the omicron variant specifically.

Categoría:

i898

Etiquetas:

, , ,

los comentarios están cerrados.